Clinical Trial: A prospective, single-arm, phase II study of neoadjuvant retlirafusp alfa injection plus SOX in patients with TGFBR2-wild-type locally advanced gastric or gastroesophageal junction adenocarcinoma (China)

Posted On: 2026-10-26

China, Oct. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-arm, phase II study of neoadjuvant retlirafusp alfa injection plus SOX in patients with TGFBR2-wild-type locally advanced gastric or gastroesophageal junction adenocarcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135037

Registration Time: 2026/10/23

Type: Interventional study

Primary Sponsor: Xijing Hospital, Air Force Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347036

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A prospective, single-arm, phase II study of neoadjuvant retlirafusp alfa injection plus SOX in patients with TGFBR2-wild-type locally advanced gastric or gastroesophageal junction adenocarcinoma (China)